Weight Navigation Program News Today

Study comparing this weight program against usual care for high risk patients shows higher use of evidence-based treatments and more weight lost

Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evide

Giving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evidence-based weight-management treatment, and led to more weight lost in just a year, a new University of Michigan study finds.

When someone has obesity, losing even 5% of their body weight can make a major difference in their health -- especially if they can keep from regaining it.

Obesity care under a health care provider’s supervision, whether through nutrition counseling, medication, meal replacement or bariatric surgery, can help peo

Last year, 3,316 semaglutide overdoses were reported by 55 poison control centers in the U.S. Compounded versions, which can contain semaglutide salts, are likely behind most of the overdoses.

Ozempic, Wegovy, and Saxenda are under investigation by the European Medicines Agency for possibly causing consumers to self-harm or experience suicidal thoughts. Clinical trials of the drug did not see this to be a large risk factor, but experts note a changing population of those taking the drugs may have shifted risk levels.

When insurance won’t pay for Ozempic, Wegovy, or Mounjaro, people are turning to cheaper, compounded semaglutide and tirzepatide — despite the risks.

When a person with diabetes, high blood pressure, or osteoarthritis goes to their primary care clinic, they expect treatment that's grounded in modern medical evidence.